Martin P. Slark
Known title: DirectorCIK: 0001012930
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Baird Upgrades Hub Group to Outperform Amid Governance Probe. Baird recently upgraded Hub Group to Outperform, maintaining a $29 price target. This move comes as the company faces a Rosen governance probe and a significant 38% decline in its stock price. The upgrade offers a counterpoint to recent negative sentiment, though the average analyst target remains higher at $37.67.
Transaction History
| NTRS | ▲ Buy | Grant | 71 | $12K | 10/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 62 | $11K | 7/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 35 | $6K | 4/21/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 989 | $0 | 4/21/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 65 | $9K | 4/1/2026 | View on chart |
| HUBG | ▼ Sell | Tax Withholding | 1,695 | $72K | 1/2/2026 | View on chart |
| HUBG | ▲ Buy | Grant | 4,679 | $0 | 1/2/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 67 | $9K | 1/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 69 | $9K | 10/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 66 | $8K | 7/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 1,902 | $0 | 4/22/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 61 | $5K | 4/22/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 72 | $7K | 4/1/2025 | View on chart |
| HUBG | ▼ Sell | Tax Withholding | 1,592 | $70K | 1/3/2025 | View on chart |
| HUBG | ▲ Buy | Grant | 4,528 | $0 | 1/3/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 68 | $7K | 1/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 78 | $7K | 10/1/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 82 | $7K | 7/1/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 70 | $6K | 4/16/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 1,822 | $0 | 4/16/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 61 | $5K | 4/1/2024 | View on chart |
| HUBG | ▼ Sell | Tax Withholding | 932 | $85K | 1/2/2024 | View on chart |
| HUBG | ▲ Buy | Grant | 2,193 | $0 | 1/2/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 63 | $5K | 1/1/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 76 | $5K | 10/1/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 70 | $5K | 7/1/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 51 | $4K | 4/25/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 1,855 | $0 | 4/25/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 47 | $4K | 4/1/2023 | View on chart |
| HUBG | ▲ Buy | Grant | 2,517 | $0 | 1/2/2023 | View on chart |
| HUBG | ▼ Sell | Tax Withholding | 879 | $70K | 1/2/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 46 | $4K | 1/1/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 47 | $4K | 10/1/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 38 | $4K | 7/1/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 1,343 | $0 | 4/26/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 30 | $3K | 4/26/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 1,343 | $0 | 4/26/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 30 | $3K | 4/26/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 25 | $3K | 4/1/2022 | View on chart |
| HUBG | ▲ Buy | Grant | 2,375 | $0 | 1/2/2022 | View on chart |
| HUBG | ▼ Sell | Tax Withholding | 1,299 | $109K | 1/2/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 24 | $3K | 1/1/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 26 | $3K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Northern Trust Q3 Earnings Loom Amid Mixed Sector News
Northern Trust is approaching its third-quarter earnings release, with analysts focusing on revenue and EPS estimates. Recent reports indicate the stock has experienced a sharp decline, joining other financial peers in a downturn. While one firm reaffirmed a positive outlook citing the company's quality, the broader sector remains under pressure.
Northern Trust Q3 Earnings Loom Amid Mixed Sector News. Northern Trust is approaching its third-quarter earnings release, with analysts focusing on revenue and EPS estimates. Recent reports indicate the stock has experienced a sharp decline, joining other financial peers in a downturn. While one firm reaffirmed a positive outlook citing the company's quality, the broader sector remains under pressure.